Pasar al contenido principal

LOS RECEPTORES DE ADENOSINA COMO DIANA EN IMMUNO-ONCOLOGIA

PID2023-150793OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2023
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 9
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Large scale investigation of GPCR molecular dynamics data uncovers allosteric sites and lateral gateways

  • Aranda-García, David|||0000-0002-5476-2903
  • Stepniewski, Tomasz Maciej|||0000-0002-6828-9192
  • Torrens-Fontanals, Mariona|||0000-0001-6233-8945
  • García Recio, Ädrian|||0000-0002-7143-9075
  • Lopez-Balastegui, Marta
  • Medel-Lacruz, Brian|||0000-0003-2831-7731
  • Morales-Pastor, Adrián
  • Peralta-García, Alejandro
  • Dieguez-Eceolaza, Miguel
  • Sotillo-Nuñez, David
  • Ding, Tianyi|||0000-0002-1989-3705
  • Drabek, Matthäus
  • Jacquemard, Célien|||0000-0002-9633-3429
  • Jakowiecki, Jakub
  • Jespers, Willem|||0000-0002-4951-9220
  • Jiménez-Rosés, Mireia|||0000-0002-4049-8670
  • Jun-Yu-Lim, Víctor
  • Nicoli, Alessandro|||0000-0001-6177-9749
  • Orzel, Urszula
  • Shahraki, Aida
  • Tiemann, Johanna K. S.|||0000-0001-7551-6245
  • Ledesma-Martin, Vicente
  • Nerín-Fonz, Francho|||0000-0002-5548-7608
  • Suárez-Dou, Sergio|||0000-0002-7929-9468
  • Canal, Oriol|||0000-0001-6292-5947
  • Pándy-Szekeres, Gáspár|||0000-0002-7697-2696
  • Mao, Jiafei
  • Gloriam, David E.|||0000-0002-4299-7561
  • Kellenberger, Esther|||0000-0002-9320-4840
  • Latek, Dorota|||0000-0002-0429-0637
  • Guixà González, Ramon|||0000-0003-0397-9800
  • Gutiérrez-de-Terán, Hugo|||0000-0003-0459-3491
  • Tikhonova, Irina G.|||0000-0002-6228-9431
  • Hildebrand, Peter Werner|||0000-0003-0063-1104
  • Filizola, Marta|||0000-0002-4382-8276
  • Babu, Madam M.|||0000-0003-0556-6196
  • Di Pizio, Antonella|||0000-0002-8520-5165
  • Filipek, Slawomir|||0000-0003-3147-3858
  • Kolb, Peter|||0000-0003-4089-614X
  • Cordomí Montoya, Arnau|||0000-0002-3848-2928
  • Giorgino, Toni|||0000-0001-6449-0596
  • Marti-Solano, Maria|||0000-0003-0373-8927
  • Selent, Jana|||0000-0002-1844-4449
G protein-coupled receptors (GPCRs) constitute a functionally diverse protein family and are targets for a broad spectrum of pharmaceuticals. Technological progress in X-ray crystallography and cryogenic electron microscopy has enabled extensive, high-resolution structural characterisation of GPCRs in different conformational states. However, as highly dynamic events underlie GPCR signalling, a complete understanding of GPCR functionality requires insights into their conformational dynamics. Here, we present a large dataset of molecular dynamics simulations covering 60% of currently available GPCR structures. Our analysis reveals extensive local "breathing" motions of the receptor on a nano- to microsecond timescale and provides access to numerous previously unexplored receptor conformational states. Furthermore, we reveal that receptor flexibility impacts the shape of allosteric drug binding sites, which frequently adopt partially or completely closed states in the absence of a molecular modulator. We demonstrate that exploring membrane lipid dynamics and their interaction with GPCRs is an efficient approach to expose such hidden allosteric sites and even lateral ligand entrance gateways. The obtained insights and generated dataset on conformations, allosteric sites and lateral entrance gates in GPCRs allows us to better understand the functionality of these receptors and opens new therapeutic avenues for drug-targeting strategies.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Large scale investigation of GPCR molecular dynamics data uncovers allosteric sites and lateral gateways

  • Aranda-García, David
  • Maciej Stępniewski, Tomasz
  • Torrens Fontanals, Mariona
  • García Recio, Adrián
  • Lopez-Balastegui, Marta
  • Medel Lacruz, Brian
  • Morales Pastor, Adrián
  • Peralta-Garcia, Alejandro
  • Dieguez-Eceolaza, Miguel
  • Sotillo-Nuñez, David
  • Ledesma-Martin, Vicente
  • Nerín-Fonz, Francho
  • Suárez-Dou, Sergio
  • Canal, Oriol
  • Selent, Jana
G protein-coupled receptors (GPCRs) constitute a functionally diverse protein family and are targets for a broad spectrum of pharmaceuticals. Technological progress in X-ray crystallography and cryogenic electron microscopy has enabled extensive, high-resolution structural characterisation of GPCRs in different conformational states. However, as highly dynamic events underlie GPCR signalling, a complete understanding of GPCR functionality requires insights into their conformational dynamics. Here, we present a large dataset of molecular dynamics simulations covering 60% of currently available GPCR structures. Our analysis reveals extensive local "breathing" motions of the receptor on a nano- to microsecond timescale and provides access to numerous previously unexplored receptor conformational states. Furthermore, we reveal that receptor flexibility impacts the shape of allosteric drug binding sites, which frequently adopt partially or completely closed states in the absence of a molecular modulator. We demonstrate that exploring membrane lipid dynamics and their interaction with GPCRs is an efficient approach to expose such hidden allosteric sites and even lateral ligand entrance gateways. The obtained insights and generated dataset on conformations, allosteric sites and lateral entrance gates in GPCRs allows us to better understand the functionality of these receptors and opens new therapeutic avenues for drug-targeting strategies., D.A.-G. acknowledges financial support from the Catalan Department of Business and Innovation (2020FISDU/487). A.G.-R. has an Investigo Programme contract funded by the European Union, Next Generation EU. T.M.S. acknowledges support from the Sara Borrell grant CD22/00007 funded by the Institute of Health Carlos III (ISCIII) and resources of grant 2021 SGR 00046 funded by Agència de Gestió d’Ajuts Universitaris i de Recerca Generalitat de Catalunya (AGAUR). B.M. acknowledges financial support from Agència de Gestió d’Ajuts Universitaris i de Recerca Generalitat de Catalunya (AGAUR) (2022 DI 00112) and DIN2021 ayudas para doctorados industriales (DIN2021-011749). A.P.-G. acknowledges support from the Spanish Ministerio de Universidades FPU program (FPU20/03069). T.G. acknowledges financial support from the Spoke 7 of the National Centre for HPC, Big Data and Quantum Computing (Centro Nazionale 01 – CN0000013), funded by the European Union -- NextGenerationEU, Mission 4, Component 2, Investment line 1.4, CUP B93C22000620006; from the PRIN 2022 (BioCat4BioPol) from the Ministero dell’Università e Ricerca, funded by the European Union -- NextGenerationEU, Mission 4 Component C2, CUP B53D23015140006; from the Spoke 5 “Next-Gen Therapeutics” of PNRR M4C2 Investiment 1.3 “HEAL ITALIA” PE_00000019, CUP H43C22000830006 project “PROPHECY-GlycoRARE”; and from the project InvAt-Invecchiamento Attivo e in Salute (FOE 2022) CUP B53C22010140001. We acknowledge CINECA awards aGPCR1 and aGPCR2 under the ISCRA initiative for the availability of high-performance computing resources and support. MMB acknowledges support from ALSAC. JS acknowledges funding from the Horizon Europe Project Obelisk under the grant agreement 101080465, the ERA-NET NEURON & Ministry of Economy, Industry, Competitiveness [AC18/00030] and the MICIU/AEI /10.13039/501100011033 and FEDER, UE (PID2022-137161OB-I00). D.E.G. acknowledges funding from the Novo Nordisk Foundation (NNF18OC0031226) and Lundbeck Foundation (R383-2022-306). H.G.-T. acknowledges funding from Ministerio de Ciencia e Innovación (PID2023-150793OB-I00). I.G.T. is supported by the Biotechnology and Biosciences Research Council responsive mode award BB/R007101/1. M.M-S. is supported by a Royal Society University Research Fellowship (URF\R1\221205). A.D.P. is supported by the Leibniz Programme for Women Professors (grant: P116/2020). D.A.-G., T.M.S, A.G.-R., A.S., A.D.P., D.E.G., G.P-S., R.G.G., T.G., I.G.T, H.G.-T., P.K., M.M.-S., J.S. have been members of COST Action CA18133 ‘ERNEST’.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Large scale investigation of GPCR molecular dynamics data uncovers allosteric sites and lateral gateways

  • Aranda-García, David
  • Stepniewski, Tomasz Maciej
  • Torrens-Fontanals, Mariona
  • García-Recio, Adrian
  • Lopez-Balastegui, Marta
  • Medel-Lacruz, Brian
  • Morales-Pastor, Adrián
  • Peralta-García, Alejandro
  • Dieguez-Eceolaza, Miguel
  • Sotillo-Nuñez, David
  • Ding, Tianyi
  • Drabek, Matthäus
  • Jacquemard, Célien
  • Jakowiecki, Jakub
  • Jespers, Willem
  • Jiménez-Rosés, Mireia
  • Jun-Yu-Lim, Víctor
  • Nicoli, Alessandro
  • Orzel, Urszula
  • Shahraki, Aida
  • Tiemann, Johanna K S
  • Ledesma-Martin, Vicente
  • Nerín-Fonz, Francho
  • Suárez-Dou, Sergio
  • Canals, Oriol
  • Pándy-Szekeres, Gáspár
  • Mao, Jiafei
  • Gloriam, David E.
  • Kellenberger, Esther
  • Latek, Dorota
  • Guixà-González, Ramon
  • Gutiérrez-de-Terán, Hugo
  • Tikhonova, Irina G.
  • Hildebrand, Peter W.
  • Filizola, Marta
  • Babu, M. Madan
  • Di Pizio, Antonella
  • Filipek, Slawomir
  • Kolb, Peter
  • Cordomi, Arnau
  • Giorgino, Toni
  • Marti-Solano, Maria
  • Selent, Jana
G protein-coupled receptors (GPCRs) constitute a functionally diverse protein family and are targets for a broad spectrum of pharmaceuticals. Technological progress in X-ray crystallography and cryogenic electron microscopy has enabled extensive, high-resolution structural characterisation of GPCRs in different conformational states. However, as highly dynamic events underlie GPCR signalling, a complete understanding of GPCR functionality requires insights into their conformational dynamics. Here, we present a large dataset of molecular dynamics simulations covering 60% of currently available GPCR structures. Our analysis reveals extensive local "breathing" motions of the receptor on a nano- to microsecond timescale and provides access to numerous previously unexplored receptor conformational states. Furthermore, we reveal that receptor flexibility impacts the shape of allosteric drug binding sites, which frequently adopt partially or completely closed states in the absence of a molecular modulator. We demonstrate that exploring membrane lipid dynamics and their interaction with GPCRs is an efficient approach to expose such hidden allosteric sites and even lateral ligand entrance gateways. The obtained insights and generated dataset on conformations, allosteric sites and lateral entrance gates in GPCRs allows us to better understand the functionality of these receptors and opens new therapeutic avenues for drug-targeting strategies., D.A.-G. acknowledges financial support from the Catalan Department of Business and Innovation (2020FISDU/487). A.G.-R. has an Investigo Programme contract funded by the European Union, Next Generation EU. T.M.S. acknowledges support from the Sara Borrell grant CD22/00007 funded by the Institute of Health Carlos III (ISCIII) and resources of grant 2021 SGR 00046 funded by Agència de Gestió d’Ajuts Universitaris i de Recerca Generalitat de Catalunya (AGAUR). B.M. acknowledges financial support from Agència de Gestió d’Ajuts Universitaris i de Recerca Generalitat de Catalunya (AGAUR) (2022 DI 00112) and DIN2021 ayudas para doctorados industriales (DIN2021-011749). A.P.-G. acknowledges support from the Spanish Ministerio de Universidades FPU program (FPU20/03069). T.G. acknowledges financial support from the Spoke 7 of the National Centre for HPC, Big Data and Quantum Computing (Centro Nazionale 01 – CN0000013), funded by the European Union -- NextGenerationEU, Mission 4, Component 2, Investment line 1.4, CUP B93C22000620006; from the PRIN 2022 (BioCat4BioPol) from the Ministero dell’Università e Ricerca, funded by the European Union -- NextGenerationEU, Mission 4 Component C2, CUP B53D23015140006; from the Spoke 5 “Next-Gen Therapeutics” of PNRR M4C2 Investiment 1.3 “HEAL ITALIA” PE_00000019, CUP H43C22000830006 project “PROPHECY-GlycoRARE”; and from the project InvAt-Invecchiamento Attivo e in Salute (FOE 2022) CUP B53C22010140001. We acknowledge CINECA awards aGPCR1 and aGPCR2 under the ISCRA initiative for the availability of high-performance computing resources and support. MMB acknowledges support from ALSAC. JS acknowledges funding from the Horizon Europe Project Obelisk under the grant agreement 101080465, the ERA-NET NEURON & Ministry of Economy, Industry, Competitiveness [AC18/00030] and the MICIU/AEI /10.13039/501100011033 and FEDER, UE (PID2022-137161OB-I00). D.E.G. acknowledges funding from the Novo Nordisk Foundation (NNF18OC0031226) and Lundbeck Foundation (R383-2022-306). H.G.-T. acknowledges funding from Ministerio de Ciencia e Innovación (PID2023-150793OB-I00). I.G.T. is supported by the Biotechnology and Biosciences Research Council responsive mode award BB/R007101/1. M.M-S. is supported by a Royal Society University Research Fellowship (URF\R1\221205). A.D.P. is supported by the Leibniz Programme for Women Professors (grant: P116/2020). D.A.-G., T.M.S, A.G.-R., A.S., A.D.P., D.E.G., G.P-S., R.G.G., T.G., I.G.T, H.G.-T., P.K., M.M.-S., J.S. have been members of COST Action CA18133 ‘ERNEST’., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Ligand and residue free energy perturbations solve the dual binding mode proposal for an A2BAR partial agonist

  • Tandarić, Tana
  • Gutiérrez-de-Terán, Hugo
Published as part of The Journal of Physical Chemistry B special issue “Applications of Free-Energy Calculations to Biomolecular Processes”., Adenosine receptors, particularly A2BAR, are gaining attention for their role in pathological conditions such as cancer immunotherapy, prompting the exploration for promising therapeutic applications. Despite numerous selective A2BAR antagonists, the lack of selective full agonists makes the partial agonist BAY60-6583 one of the most interesting activators of this receptor. Recent cryo-EM structures have univocally revealed the binding mode of nonselective ribosidic agonists such as adenosine and its derivative NECA to A2BAR; however, two independent structures with BAY60-6583 show alternative binding orientations, raising the question of which is the physiologically relevant binding mode. In situations such as this, computational simulations that accurately predict shifts in binding free energy can complement experimental structures. Our study combines QligFEP and QresFEP protocols to directly compare the binding affinity of BAY60-6583 between alternative binding modes as well as providing a direct comparison of in silico mutagenesis studies on each pose with experimental mutational effects. Both methods converge on the experimentally determined binding mode that better explains both the existing SAR and mutagenesis data for this ligand. Our results allow the elucidation of the experimental binding orientation that should be considered as a basis for designing partial agonist derivatives with improved affinity and selectivity and underscore the value of free energy perturbation methods in aiding structure-based drug design., This study was supported by grant PID2023-150793OB-I00 from the Spanish Ministry of Science and Innovation. Computations were enabled by resources provided by the National Academic Infrastructure for Supercomputing in Sweden (NAISS) and the Swedish National Infrastructure for Computing (SNIC) partially funded by the Swedish Research Council through grant agreements no. 2022-06725 and no. 2018-05973., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Accurate predictions of protein mutational effects accelerated with a hybrid-topology free energy protocol

  • Koenekoop, Lucien
  • Brug, Nadine van de
  • Jespers, Willem
  • Åqvist, Johan
  • Gutiérrez-de-Terán, Hugo
Quantifying the effects of point mutations is of utmost interest for pharmaceutical and biotechnological applications. Reliable computational methods range from statistical and AI-based to physics-based approaches, with the optimal balance between accurate and fast predictions remaining a challenge. Free energy perturbation (FEP) simulations, a powerful physics-based approach available for decades, constitutes nowadays a method of common application in protein mutational studies. We present QresFEP-2, a novel hybrid-topology FEP protocol benchmarked on a comprehensive protein stability dataset of 10 protein systems, encompassing almost 600 mutations. QresFEP-2 combines excellent accuracy with the highest computational efficiency among available FEP protocols, and its robustness is further validated through comprehensive domain-wide mutagenesis, assessing the thermodynamic stability of over 400 mutations generated by a systematic mutation scan of the 56-residue B1 domain of streptococcal protein G (Gβ1). We also demonstrate the applicability domain of QresFEP-2 on evaluating site-directed mutagenesis effects on protein-ligand binding, tested on a GPCR, as well as on protein-protein interactions examined on the barnase/barstar complex. QresFEP-2 emerges as an open-source, physics-based alternative for advancing protein engineering, drug design, and elucidating the impact of mutations on human health., Support from the Swedish Research Council (grant no. 2022-03441) and the Knut and Alice Wallenberg Foundation (grant no. 2023.0210) is gratefully acknowledged. This study was supported by grant PID2023- 150793OB-I00 from the Spanish Ministry of Science and Innovation – State Research Agency – FEDER-UE, and is part of the project Novel Oncological Targets – Inhibiting Cancer via Mutated G Proteins with file number VI.Veni.232.243 (partly) financed by the Dutch Research Council (NWO). Computational resources were provided by the National Academic Infrastructure for Supercomputing in Sweden (NAISS) partially funded by the Swedish Research Council through grant agreements no. 2022-06725 and no. 2018-05973., Open access funding provided by Uppsala University., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Otros (Other)

La visión de los agentes medioambientales sobre las tendencias poblacionales de conejo y los daños a la agricultura en Castilla-La Mancha

  • Delibes-Mateos, Miguel
  • Villafuerte, Rafael
  • Arroyo, Beatriz
  • Garrido Fernández, Fernando E.
  • Glikman, Jenny Anne
  • Morales-Reyes, Zebensui
  • Martínez-Jauregui, María
Este estudio formó parte del proyecto TED2021-132034B-I00, financiado por MCIN/AEI/10.13039/501100011033 y la Unión Europea “NextGenerationEU”/PRTR” y contribuye al proyecto PID2023-15079OB-100, financiado por MCIN/AEI/10.13039/501100011033 y por FEDER, UE. Agradecemos especialmente a los agentes medioambientales de Castilla-La Mancha por haber participado en este proyecto., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Doing more with less: Accurate and scalable ligand free energy calculations by focusing on the binding site

  • Alencar Araripe, David
  • Díaz-Holguín, Alejandro
  • Poso, Antti
  • Westen, Gerard J. P. van
  • Åqvist, Johan
  • Gutiérrez-de-Terán, Hugo
  • Jespers, Willem
Predicting how chemical modifications affect drug binding is central to rational drug design. Free energy perturbation (FEP) calculations provide accurate estimates of these binding affinity changes, but existing methods often require substantial computational resources and expert knowledge. Here, we present QligFEP v2.1.0, a flexible open-source workflow based on a graphical and command-line interface for calculating relative binding free energies using spherical boundary conditions, which dramatically reduces simulation system size by confining simulations to a focused region around the binding site. QligFEP features a configurable restraint algorithm that automatically handles diverse chemical transformations, streamlined setup procedures, and enhanced analysis tools. We validated the method using industry benchmarks comprising 16 protein targets and 639 ligand transformations. Statistical analysis demonstrates that QligFEP achieves comparable accuracy to established commercial and open-source alternatives while requiring only a fraction of the computational resources. The perturbation protocol simulates ∼6250 atoms per perturbation leg and completes transformation replicates in under 2 h on standard computational clusters. Unlike full-system simulations, QligFEP’s modest computational requirements make FEP accessible for less than $1 on current AWS spot instances. The combination of accuracy, flexibility, and computational efficiency positions QligFEP as a practical solution for accelerating compound optimization in drug discovery, making rigorous binding affinity predictions accessible for large scale applications and to research groups with limited computational infrastructure., D.A.A. was supported by funding from the European Union’s Horizon 2020 research and innovation program under the Marie Skłodowska Curie grant agreement No 955879. Support from the Swedish Research Council (grant no. 2022-03441) and the Knut and Alice Wallenberg Foundation (grant no. 2023.0210) is gratefully acknowledged. This work is part of the project Novel Oncological Targets – Inhibiting Cancer via Mutated G Proteins with file number VI.Veni.232.243 (partly) financed by the Dutch Research Council (NWO). This study was supported by grant PID2023- 150793OB-I00 from the Spanish Ministry of Science and Innovation – State Research Agency – FEDER-UE. W.J. is grateful for the opportunities and support afforded by the Sector Plan Pharmaceutical Sciences, implemented in the overarching Sector Plan Beta II and put into action by the Ministry of Education, Culture, and Science (OCW) of The Netherlands. This work used the Dutch national e-infrastructure with the support of the SURF Cooperative using grant no. EINF-14715. Computational resources were provided by the National Academic Infrastructure for Supercomputing in Sweden (NAISS) partially funded by the Swedish Research Council through grant agreements no. 2022-06725 and no. 2018-05973., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

An integrative biophysical and computational workflow uncovers new allosteric sites and modulators of the human A2A adenosine receptor

  • Prudent, Renaud
  • Tandarić, Tana
  • Gutiérrez-de-Terán, Hugo
  • Eddy, Matthew T.
Renaud Prudent; Matthew T. Eddy; et al., Allosteric modulators offer a promising approach for targeting receptor function in pathological contexts. Although numerous orthosteric ligands have been developed, the discovery of allosteric inhibitors remains limited, hindered by challenges with identifying modulators and the perceived lower druggability of allosteric sites. In this study, we employed affinity selection–mass spectrometry (AS–MS) with a chemically diverse library to identify novel allosteric modulators of the human A2A adenosine receptor (A2AAR). Subsequent competition binding and orthogonal biophysical assays confirmed the allosteric nature of multiple initial hits, underscoring the sensitivity and utility of the AS–MS approach. Despite exhibiting relatively weak affinity, these compounds modulated cAMP production, supporting the idea that allosteric modulators can exert functional effects without requiring high potency to outcompete endogenous adenosine. Experiments in the presence of an A2AAR agonist further supported the classification of these compounds as negative allosteric modulators (NAMs), with distinct pharmacological profiles indicative of diverse mechanisms of action. An integrated computational workflow designed to predict allosteric sites and model ligand interactions provided insight into potential binding poses, yielding both intracellular and extracellular allosteric sites that aligned with the experimentally observed pharmacological properties. The identification of these previously uncharacterized NAMs represents an important step toward developing alternative A2AAR-targeted therapies, enabling pharmacological intervention through receptor sites beyond the orthosteric binding pocket., N.T., A.P.R., and M.T.E. were supported by an NIH MIRA award R35GM138291. This work was supported by the Fondation pour la Recherche Médicale (Equipe FRM EQU202503020060, to R.J.), This work was supported by the Agence Nationale de la Recherche (ANR- 23-CE18-0008 SENS-AD, to E.C.), the Fondation de la Recherche Médicale (MND202310017920, to E.C.), “Projet de recherche international” (PRI) Inserm édition 2023, Institut National de la Santé et de la Recherche Médicale (INSERM), and Centre National de la Recherche Scientifique (CNRS). This study was supported by grant PID2023-150793OB-I00 from the Spanish Ministry of Science and Innovation. Computations were enabled by resources provided by the National Academic Infrastructure for Supercomputing in Sweden (NAISS) and the Swedish National Infrastructure for Computing (SNIC), partially funded by the Swedish Research Council through grant agreement no. 2022-06725 and no. 2018-05973., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Large scale investigation of GPCR molecular dynamics data uncovers allosteric sites and lateral gateways

  • Aranda-García, David
  • Maciej Stępniewski, Tomasz
  • Torrens Fontanals, Mariona
  • García Recio, Adrián
  • Lopez-Balastegui, Marta
  • Medel Lacruz, Brian
  • Morales Pastor, Adrián
  • Peralta-Garcia, Alejandro
  • Dieguez-Eceolaza, Miguel
  • Sotillo-Nuñez, David
  • Ledesma-Martin, Vicente
  • Nerín-Fonz, Francho
  • Suárez-Dou, Sergio
  • Canal, Oriol
  • Selent, Jana
G protein-coupled receptors (GPCRs) constitute a functionally diverse protein family and are targets for a broad spectrum of pharmaceuticals. Technological progress in X-ray crystallography and cryogenic electron microscopy has enabled extensive, high-resolution structural characterisation of GPCRs in different conformational states. However, as highly dynamic events underlie GPCR signalling, a complete understanding of GPCR functionality requires insights into their conformational dynamics. Here, we present a large dataset of molecular dynamics simulations covering 60% of currently available GPCR structures. Our analysis reveals extensive local "breathing" motions of the receptor on a nano- to microsecond timescale and provides access to numerous previously unexplored receptor conformational states. Furthermore, we reveal that receptor flexibility impacts the shape of allosteric drug binding sites, which frequently adopt partially or completely closed states in the absence of a molecular modulator. We demonstrate that exploring membrane lipid dynamics and their interaction with GPCRs is an efficient approach to expose such hidden allosteric sites and even lateral ligand entrance gateways. The obtained insights and generated dataset on conformations, allosteric sites and lateral entrance gates in GPCRs allows us to better understand the functionality of these receptors and opens new therapeutic avenues for drug-targeting strategies., D.A.-G. acknowledges financial support from the Catalan Department of Business and Innovation (2020FISDU/487). A.G.-R. has an Investigo Programme contract funded by the European Union, Next Generation EU. T.M.S. acknowledges support from the Sara Borrell grant CD22/00007 funded by the Institute of Health Carlos III (ISCIII) and resources of grant 2021 SGR 00046 funded by Agència de Gestió d’Ajuts Universitaris i de Recerca Generalitat de Catalunya (AGAUR). B.M. acknowledges financial support from Agència de Gestió d’Ajuts Universitaris i de Recerca Generalitat de Catalunya (AGAUR) (2022 DI 00112) and DIN2021 ayudas para doctorados industriales (DIN2021-011749). A.P.-G. acknowledges support from the Spanish Ministerio de Universidades FPU program (FPU20/03069). T.G. acknowledges financial support from the Spoke 7 of the National Centre for HPC, Big Data and Quantum Computing (Centro Nazionale 01 – CN0000013), funded by the European Union -- NextGenerationEU, Mission 4, Component 2, Investment line 1.4, CUP B93C22000620006; from the PRIN 2022 (BioCat4BioPol) from the Ministero dell’Università e Ricerca, funded by the European Union -- NextGenerationEU, Mission 4 Component C2, CUP B53D23015140006; from the Spoke 5 “Next-Gen Therapeutics” of PNRR M4C2 Investiment 1.3 “HEAL ITALIA” PE_00000019, CUP H43C22000830006 project “PROPHECY-GlycoRARE”; and from the project InvAt-Invecchiamento Attivo e in Salute (FOE 2022) CUP B53C22010140001. We acknowledge CINECA awards aGPCR1 and aGPCR2 under the ISCRA initiative for the availability of high-performance computing resources and support. MMB acknowledges support from ALSAC. JS acknowledges funding from the Horizon Europe Project Obelisk under the grant agreement 101080465, the ERA-NET NEURON & Ministry of Economy, Industry, Competitiveness [AC18/00030] and the MICIU/AEI /10.13039/501100011033 and FEDER, UE (PID2022-137161OB-I00). D.E.G. acknowledges funding from the Novo Nordisk Foundation (NNF18OC0031226) and Lundbeck Foundation (R383-2022-306). H.G.-T. acknowledges funding from Ministerio de Ciencia e Innovación (PID2023-150793OB-I00). I.G.T. is supported by the Biotechnology and Biosciences Research Council responsive mode award BB/R007101/1. M.M-S. is supported by a Royal Society University Research Fellowship (URF\R1\221205). A.D.P. is supported by the Leibniz Programme for Women Professors (grant: P116/2020). D.A.-G., T.M.S, A.G.-R., A.S., A.D.P., D.E.G., G.P-S., R.G.G., T.G., I.G.T, H.G.-T., P.K., M.M.-S., J.S. have been members of COST Action CA18133 ‘ERNEST’.